We have successfully concluded our MicroED/3DED workshop at APMC13 yesterday! A huge thank you to @XUEY85 , @weixi_gu , all the participants and the APMC13 conference organisers for their support and efforts. @CMMUQ1
Excited to share our work in @PNASNews .
We report the cryoEM structures of both TRIF and TRAM uncovering the molecular basis of TRIF-mediated TLR3 and TLR4 signalling pathways.
https://t.co/jDe1hMssf4
It’s my great honour to be an ARC Future Fellowship 2024 recipient. It’s been a dream start for me to establish my own group @ANUChemistry@ourANU. Thanks to @UQ_SCMB, @UQscience and @CMMUQ1 for supporting my application. We will continue to collaborating closely.
We have a #PhDscholarship available for domestic student. The project will focus on structural and functional characterization of a particular set of TIR domain-containing proteins. For more details please see https://t.co/ea3iOU9E7z and contact Bostjan Kobe at [email protected].
We’re #hiring! A #postdoc is available in Kobe lab to work on structure-guided inhibitor design of proteins involved in immune system.
See job advertisement at https://t.co/W2ZC92QUcr. Apply by 13th August 2024 11:00 pm. #structuralbiology#drugdesign
As the first lab showing a neurotoxic effect of the NAD precursor NMN, we discuss links between NMN, other NAD precursors, SARM1 and anti-ageing supplements in our latest review on this controversial topic. @LabColeman
#SARM1#NMN#ageing
https://t.co/4ffXQ88Quz
Excited to share our amazing plant structural work at the STROMLO plant pathology conference! Come down and say hi to us !!! @NatsumiMaruta@MitchellSorbel2@Dalton_Ngu
We're honoured to receive Award for outstanding contribution to research recognising Kobe lab's contributions to @UQ_SCMB research in 2022! We owe thanks to all our collaborators, including Michael @buffalo_berger, Mark Schembri. @JeffNanson@weixi_gu@manikrpc
From 2023, NHMRC will award equal numbers of Investigator Grants to women and men in a new intervention to address gender inequities in research funding. https://t.co/45LsSsWh23 1/2
CDCP1 is highly expressed in many cancers compared to normal tissues and so, CDCP1 is perfect target to deliver payloads for diagnosis and treatment of cancers. Check out our Lab's recently published paper on theranostics! https://t.co/2ranPnUva1 @TashbibK@TomaKryza
#ComBio2022@ComBio2022
Congratulations 👏🎉 to the winners of the Welcome mixer night prize draw at @Eppendorf_Group booth. Please come and collect your prizes 🤩
Still time to enter the draw for today! Visit the booth, scan our QR code and complete the survey. #Prizes